Price target
3.60RUSD+2.8338+369.85%
The 5 analysts offering 1 year price forecasts for Lexicon Pharmaceuticals, Inc. have a max estimate of 10.00 and a min estimate of 0.8000.
Analyst rating
Based on 6 analysts giving stock ratings to Lexicon Pharmaceuticals, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
4
Buy
0
Hold
2
Sell
0
Strong sell
0
EPS
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
−0.24
−0.18
−0.12
−0.06
0.00
Reported
Estimate
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Reported
−0.17
−0.22
−0.21
−0.20
−0.20
−0.17
−0.18
—
—
—
—
Estimate
−0.18
−0.17
−0.21
−0.22
−0.18
−0.18
−0.16
−0.13
−0.12
−0.12
−0.13
Surprise
+5.21%
−25.96%
+2.17%
+7.91%
−11.11%
+3.95%
−10.54%
—
—
—
—
Revenue
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
0.00
1.70 M
3.40 M
5.10 M
6.80 M
Reported
Estimate
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Reported
24.00 K
317.00 K
162.00 K
702.00 K
1.10 M
1.65 M
1.75 M
—
—
—
—
Estimate
33.33 K
66.67 K
2.06 M
1.25 M
1.40 M
3.44 M
2.99 M
6.48 M
3.05 M
3.86 M
5.67 M
Surprise
−28.00%
+375.50%
−92.14%
−43.88%
−21.43%
−52.06%
−41.54%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
LXRX EPS for the last quarter is −0.18 USD despite the estimation of −0.16 USD. In the next quarter EPS is expected to reach −0.13 USD. Track more of Lexicon Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Lexicon Pharmaceuticals, Inc. revenue is expected to reach 6.48 M USD. Check out Lexicon Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, LXRX price target is 3.60 USD with a max estimate of 10.00 USD and a min estimate of 0.80 USD. Check if this forecast comes true in a year, meanwhile watch Lexicon Pharmaceuticals, Inc. stock price chart and keep track of the current situation with LXRX news and stock market news.
We've gathered opinions of 6 analysts rating LXRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.